GENE ONLINE|News &
Opinion
Blog

2025-11-30|

Study Introduces Waist-to-Arm Ratio as Tool for Detecting Sarcopenic Obesity in Older Adults

by GOAI
Share To

A recent study highlights the Waist-to-Arm Ratio (WAR) as a potential tool for identifying sarcopenic obesity in older adults. Researchers, led by Cheng et al., introduced this metric to assess the relationship between body composition and functional health outcomes in aging populations. The findings, published in *BMC Geriatrics*, suggest that WAR could serve as an important index for detecting this condition, which combines muscle loss (sarcopenia) with excess fat accumulation.

The study emphasizes the growing need for precise and accessible methods to evaluate sarcopenic obesity, particularly given its impact on mobility and overall health in older individuals. By focusing on the ratio of waist circumference to arm circumference, researchers propose that WAR offers a simple yet effective way to measure changes in body composition associated with aging. This approach may provide healthcare professionals with a practical tool for early detection and intervention strategies aimed at improving quality of life among elderly populations.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top